Pharmacogenetic Clinical Trial of Nepicastat for Post Traumatic Stress Disorder (PTSD)

NCT00641511 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

FED

Sponsor class

Stopped Houston site withdrew as a study site.

Conditions

Post Traumatic Stress Disorder (PTSD)

Interventions

DRUG: SYN117 (nepicastat)
DRUG: Placebo comparator

Sponsor

Michael E. DeBakey VA Medical Center

Collaborators

[object Object]
[object Object]
[object Object]